8028 - Rivastigmine

Material & Volume
  • Serum, 1ml
Reference values
Age Sex Pregnant Range Unit
All No 8.0-20.0 1-2h after oral administration
5.0-13.0 1h before taking a new batch
>40.0 toxic
μg/l
Clinical Information

Type of drug: Antidementive
Metabolism: Cholinesterase
Half life t½: 1-2h
Steady State: 1 day
TDM: useful
Additional informations: Due to the short t½, Cmax should be determined for oral application. For depot applications, Cmin can be determined normally. Positive correlation between rivastigmine concentration and inhibition of AChEA.

More information
Position / Price
Position: 1579.00
Price: CHF 126.00
+ Processing fee:
(per order and per day)
CHF 21.60
Executing laboratory
External service
Execution time
7 days
Contact
During opening-hours:
Outside opening-hours: